Huawei Unveils Three-step “ACT” Pathway and Nine Major Solutions for Industrial Intelligence
—Breaking New Ground to Industrial Intelligence SHANGHAI, Sept. 20, 2025 /PRNewswire/ --…
Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer’s Disease
TAINAN, June 13, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the…
Miles Education and St. James School of Medicine partner to enable Indian NEET Qualifiers to become Licensed U.S. Doctors
BANGALORE, India, June 4, 2025 /PRNewswire/ -- Miles Education, a global ed-tech leader…
